# Tongli Pharmaceuticals (USA), Inc.

Tongli Pharmaceuticals (USA), Inc. is a company headquartered in New York, NY, United States.

## Company overview

- **Legal name:** Tongli Pharmaceuticals (USA), Inc.
- **Former names in filing history:** American Tony Pharmaceuticals, Inc. (2008-09-24 to 2008-10-30); AIM SMART CORP (1999-06-14 to 2008-09-03)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** New York, NY, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001052284

## About

Tongli Pharmaceuticals (USA), Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001052284, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2013-06-28, it reported net income of USD 1,493,484; total assets of USD 22,060,023 for the fiscal period ended 2013-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2012 (period ended 2013-03-31)

- **Net income:** $1.5M (USD 1,493,484)
- **Total assets:** $22.1M (USD 22,060,023)
- **Operating cash flow:** $6.0M (USD 6,038,030)

### FY2011 (period ended 2012-03-31)

- **Net income:** $2.2M (USD 2,151,772)
- **Total assets:** $19.8M (USD 19,841,675)
- **Operating cash flow:** -$285,025 (USD -285,025)

## Recent SEC filings

- Form 10-Q — filed 2014-02-14 — period 2013-12-31 — FORM 10-Q
- Form 10-Q — filed 2013-11-14 — period 2013-09-30 — FORM 10-Q
- Form 10-Q — filed 2013-08-19 — period 2013-06-30 — FORM 10-Q
- Form 10-K — filed 2013-06-28 — period 2013-03-31 — FORM 10-K
- Form 10-Q — filed 2013-02-14 — period 2012-12-31 — FORM 10-Q
- Form 10-Q — filed 2012-11-14 — period 2012-09-30 — FORM 10-Q
- Form 10-Q — filed 2012-08-14 — period 2012-06-30 — FORM 10-Q
- Form 10-K/A — filed 2012-07-24 — period 2012-03-31 — AMENDMENT NO. 1
- Form 10-K — filed 2012-07-16 — period 2012-03-31 — FORM 10-K
- Form 8-K — filed 2012-04-10 — period 2012-04-09 — CURRENT REPORT
- Form 10-Q — filed 2012-02-14 — period 2011-12-31 — 10-Q
- Form 8-K — filed 2011-12-13 — period 2011-12-12 — FORM 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/tongli-pharmaceuticals-usa-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology